Title: Research Scientist in Genomics and Parasitology
Company: New England Biolabs
Location: Belmont, Massachusetts, United States
Dr. Amit Sinha, research scientist at New England Biolabs, has been recognized by Marquis Who’s Who Top Scientists for dedication, achievements and leadership in genomics and parasitology.
Dr. Sinha has established an esteemed career in genomics and parasitology, having excelled as a research scientist at New England Biolabs since 2020. In this capacity, he conducts pioneering research and defines new areas of study that align with the aforementioned company’s mission, with a particular emphasis on neglected tropical disease research. Recognized for his expertise in genomics for neglected tropical diseases, parasitology research and infectious disease research, Dr. Sinha is responsible for extensive data analysis of large-scale genomics datasets, comprehensive literature review and the planning of numerous experiments. Additionally, he supervises doctoral students, postdoctoral researchers and summer students in the laboratory, fostering the next generation of scientists.
Among Dr. Sinha’s most notable achievements is the development of an innovative genome sequencing method designed to identify new viruses in disease vectors such as deer ticks, which are a significant concern in New England. This novel research tool is expected to be published soon and will enable researchers to accomplish previously challenging tasks more efficiently, saving time and resources while facilitating discoveries with important implications for human health.
Dr. Sinha began his tenure at New England Biolabs in 2017 as a postdoctoral researcher, where he completed three years of postdoctoral training before transitioning into his current permanent role. His work has consistently contributed to advancing the company’s goals and expanding its impact within the scientific community.
Prior to joining New England Biolabs, Dr. Sinha was active as a postdoctoral researcher at the University of Massachusetts Medical School in Worcester from 2013 to 2017. During this period, he further honed his skills in infectious disease research and genomics, contributing to several high-impact projects and publications.
In 2013, Dr. Sinha held a postdoctoral researcher position at the Max Planck Institute for Developmental Biology in Tübingen, Germany. Near the beginning of his career, he worked as a software engineer at Infosys from 2002 to 2003. This foundational experience provided him with valuable computational skills that would later prove essential in his transition to biological data analysis.
To support his professional ambitions, Dr. Sinha pursued an education at the Indian Institute of Technology Kanpur, from which he earned a Bachelor of Technology in materials and metallurgical engineering in 2002. He continued his studies with a Master of Technology in biological sciences and bioengineering at the aforementioned institute in 2007. He ultimately concluded his academic efforts at the Max Planck Institute for Developmental Biology in Tübingen, Germany, graduating with a Doctor of Philosophy in evolutionary developmental biology, magna cum laude, in 2012. His decision to pursue a career in biology was influenced by the release of the human genome around the time of his undergraduate graduation—a milestone that sparked widespread excitement about computational methods for analyzing sequence data and inspired Dr. Sinha’s entry into this rapidly evolving field.
Throughout his career, Dr. Sinha has credited his success to the unwavering support of his parents and mentors who encouraged his passions and took risks on his behalf. He also attributes his achievements to his curiosity, broad scientific interests and dedication to staying informed about policy updates and technological advancements impacting public health worldwide.
Dr. Sinha is an active member of several notable organizations, including the American Society for Tropical Medicine and Hygiene since 2019 and the Genetics Society of America since 2011. These affiliations reflect his commitment to advancing scientific knowledge and engaging with peers across disciplines.
Dr. Sinha’s contributions to his field extend beyond research through volunteer service as a reviewer and editor for scientific journals as well as charitable donations supporting various causes. His scholarly output includes numerous peer-reviewed articles and book chapters covering topics such as genome sequencing technologies, metagenomics, molecular surveillance of parasites and symbiotic relationships between bacteria and disease vectors. Notable publications to his credit include “Cappable-Seq reveals the transcriptional landscape of stress responses in the bacterial endosymbiont Wolbachia” for bioRxiv in 2024, “Microbiome and mitogenomics of the chigger mite Pentidionis agamae: Potential role as an Orientia vector” for BMC Genomics in 2024, “High-throughput nanopore DNA sequencing of large insert fosmid clones directly from bacterial colonies” for Applied and Environmental Microbiology in 2024, among many others spanning leading journals such as Scientific Reports, The Journal of Infectious Diseases, Genome Biology and Evolution and PLoS Pathogens.
Born in India, Dr. Sinha maintains a strong interest in infectious diseases both professionally and personally. His career exemplifies dedication to scientific advancement through rigorous research, mentorship and civic engagement—qualities that have earned him recognition among leaders in genomics and infectious disease research worldwide.
Looking toward the future, Dr. Sinha aims to make significant contributions to research on neglected tropical diseases—an objective that aligns closely with both his division’s mission at New England Biolabs and his personal commitment to improving human health globally, particularly within resource-limited settings. He seeks to expand his research group’s reach while integrating emerging technologies such as machine learning and artificial intelligence for large-scale biological data analysis.
For more information, please visit:
Press Release
LinkedIn
Contact Dr. Sinha: